Trial Profile
A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2014
Price :
$35
*
At a glance
- Drugs AS 101 (Primary)
- Indications Acquired immunodeficiency syndrome
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Apr 2014 New trial record